ARCHIVES

Three NCAB Members Say They Cannot Offer “Strong Endorsement” Of P-4 Trial.

This article is from The Cancer Letter archive.

Vol. 33 No. 23 | June 15, 2007

Download PDF Visit The Full Archive

Related Articles

Texas Oncology Designated Aranesp As Preferred Treatment

December 13, 2002

Cancer center investigators share Nobel Prizes in medicine, chemistry.

October 8, 2004

In Brief: NCI Holds Paylines To 160, 165 for Now While Anticipating Another OMB Rescission Request

November 14, 1986

In Brief: Evaluation Of Potential Immunoassay Components Sought; Promising Results Could Lead to Contract

September 19, 1975

Experts Call For Large International Study Of Mammography Screening In Ages 40-42

October 15, 1993

NCI Advisory Board Approves Three Concepts

December 19, 2014